BIOMAT Database Logo BIOMAT Database Logo

[Azelastine: evaluation of the protective effects in induced bronchospasm challenges]. 1987

C Marzo, and A Cammarata, and G Mazzarella, and M Ciampini, and F Bianchi, and E Catena

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010793 Phthalazines Bicyclic heterocyclic compounds containing a BENZENE ring fused to PYRIDAZINE.
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D001986 Bronchial Spasm Spasmodic contraction of the smooth muscle of the bronchi. Bronchospasm,Bronchial Spasms,Bronchospasms,Spasm, Bronchial,Spasms, Bronchial
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines

Related Publications

C Marzo, and A Cammarata, and G Mazzarella, and M Ciampini, and F Bianchi, and E Catena
Evaluation of protective effect of fenoterol in allergen-induced bronchospasm.
January 1983, Allergy,
C Marzo, and A Cammarata, and G Mazzarella, and M Ciampini, and F Bianchi, and E Catena
Protective effect of aminophylline in induced bronchospasm.
January 1977, Review of Czechoslovak medicine,
C Marzo, and A Cammarata, and G Mazzarella, and M Ciampini, and F Bianchi, and E Catena
The protective effect of ketotifen in exercise-induced bronchospasm.
January 1988, Allergologia et immunopathologia,
C Marzo, and A Cammarata, and G Mazzarella, and M Ciampini, and F Bianchi, and E Catena
[Protective effects of nifedipine, DSCG and salbutamol in bronchospasm induced by ultrasonic mist].
January 1987, Archivio Monaldi per le malattie del torace,
C Marzo, and A Cammarata, and G Mazzarella, and M Ciampini, and F Bianchi, and E Catena
The protective effect of methylprednisolone on carbachol-induced bronchospasm.
December 1984, The American review of respiratory disease,
C Marzo, and A Cammarata, and G Mazzarella, and M Ciampini, and F Bianchi, and E Catena
[Protective effect of aminophylline in induced bronchospasm (author's transl)].
November 1976, Casopis lekaru ceskych,
C Marzo, and A Cammarata, and G Mazzarella, and M Ciampini, and F Bianchi, and E Catena
Exercise-induced bronchospasm: evaluation of metaproterenol.
May 1968, Annals of allergy,
C Marzo, and A Cammarata, and G Mazzarella, and M Ciampini, and F Bianchi, and E Catena
Evaluation of the protective effect of a new beta-agonist, KWD 2131, on allergen-induced bronchospasm.
July 1980, Allergy,
C Marzo, and A Cammarata, and G Mazzarella, and M Ciampini, and F Bianchi, and E Catena
Evaluation of exercise-induced bronchospasm in the adult asthmatic.
November 1976, The Journal of allergy and clinical immunology,
C Marzo, and A Cammarata, and G Mazzarella, and M Ciampini, and F Bianchi, and E Catena
The protective effect of inhaled BRL 10833 on allergen induced bronchospasm.
September 1976, Clinical allergy,
Copied contents to your clipboard!